Portaccio et al.1 reported that fetal exposure to natalizumab increases the risk of spontaneous abortions and congenital anomalies. The authors also described one autism spectrum disorder (ASD) and one language… Click to show full abstract
Portaccio et al.1 reported that fetal exposure to natalizumab increases the risk of spontaneous abortions and congenital anomalies. The authors also described one autism spectrum disorder (ASD) and one language disorder case.
               
Click one of the above tabs to view related content.